{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:32:11Z","timestamp":1740547931978,"version":"3.38.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"New National Excellence Program of the Ministry for Innovation and Technology from the Source of the National Research","award":["UNKP-23-3-II-DE-388"],"award-info":[{"award-number":["UNKP-23-3-II-DE-388"]}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"crossref","award":["BO\/00127\/21\/8"],"award-info":[{"award-number":["BO\/00127\/21\/8"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["FK138462"],"award-info":[{"award-number":["FK138462"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11046-024-00919-1","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T14:45:13Z","timestamp":1735310713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolate Specific Transcriptome Changes Exerted by Isavuconazole Treatment in Candida auris"],"prefix":"10.1007","volume":"190","author":[{"given":"No\u00e9mi","family":"Balla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fruzsina","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Harmath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliz","family":"Boz\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Majoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-2424","authenticated-orcid":false,"given":"Ren\u00e1t\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-0656","authenticated-orcid":false,"given":"\u00c1gnes","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"2","key":"919_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1128\/AAC.01079-10","volume":"55","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Moet GJ, Messer SA, et al. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008\u20132009. Antimicrob Agents Chemother. 2011;55(2):561\u20136. https:\/\/doi.org\/10.1128\/AAC.01079-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"919_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115016","volume":"97","author":"MA Pfaller","year":"2020","unstructured":"Pfaller MA, Carvalhaes CG, Smith CJ, et al. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012\u20132017). Diagn Microbiol Infect Dis. 2020;97(2): 115016. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115016.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"919_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263522","volume":"17","author":"MB Atiencia-Carrera","year":"2022","unstructured":"Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, et al. Prevalence of biofilms in Candida spp. bloodstream infections: a meta-analysis. PLoS One. 2022;17(2): e0263522.","journal-title":"PLoS One"},{"issue":"3","key":"919_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/1348-0421.12568","volume":"62","author":"K Satoh","year":"2018","unstructured":"Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. Nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2018;62(3):205. https:\/\/doi.org\/10.1111\/1348-0421.12568.","journal-title":"Microbiol Immunol"},{"issue":"10","key":"919_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008921","volume":"16","author":"H Du","year":"2020","unstructured":"Du H, Bing J, Hu T, et al. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020;16(10): e1008921. https:\/\/doi.org\/10.1371\/journal.ppat.1008921.","journal-title":"PLoS Pathog"},{"key":"919_CR6","unstructured":"https:\/\/www.cdc.gov\/media\/releases\/2023\/p0320-cauris.html"},{"issue":"46","key":"919_CR7","doi-asserted-by":"publisher","first-page":"2200846","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200846","volume":"27","author":"A Kohlenberg","year":"2022","unstructured":"Kohlenberg A, Monnet DL, Plachouras D, et al. Increasing number of cases and outbreaks caused by Candida auris in the EU\/EEA, 2020 to 2021. Euro Surveill. 2022;27(46):2200846.","journal-title":"Euro Surveill"},{"issue":"8","key":"919_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/apm.13336","volume":"131","author":"P Jangir","year":"2023","unstructured":"Jangir P, Kalra S, Tanwar S, et al. Azole resistance in Candida auris: mechanisms and combinatorial therapy. APMIS. 2023;131(8):442\u201362. https:\/\/doi.org\/10.1111\/apm.13336.","journal-title":"APMIS"},{"issue":"3","key":"919_CR9","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001318","volume":"70","author":"A Chakrabarti","year":"2021","unstructured":"Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. J Med Microbiol. 2021;70(3): 001318. https:\/\/doi.org\/10.1099\/jmm.0.001318.","journal-title":"J Med Microbiol"},{"key":"919_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","volume":"77","author":"A Chowdhary","year":"2023","unstructured":"Chowdhary A, Jain K, Chauhan N. Candida auris genetics and emergence. Annu Rev Microbiol. 2023;77:583\u2013602. https:\/\/doi.org\/10.1146\/annurev-micro-032521-015858.","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"919_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00498-23","volume":"11","author":"P Brandt","year":"2023","unstructured":"Brandt P, Mirhakkak MH, Wagner L, et al. High-throughput profiling of Candida auris isolates reveals clade-specific metabolic differences. Microbiol Spectr. 2023;11(3): e0049823. https:\/\/doi.org\/10.1128\/spectrum.00498-23.","journal-title":"Microbiol Spectr"},{"issue":"8","key":"919_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007460","volume":"15","author":"S Singh","year":"2019","unstructured":"Singh S, Uppuluri P, Mamouei Z, et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog. 2019;15(8): e1007460. https:\/\/doi.org\/10.1371\/journal.ppat.1007460.","journal-title":"PLoS Pathog"},{"issue":"5","key":"919_CR13","doi-asserted-by":"publisher","first-page":"00339","DOI":"10.1128\/mSphere.00339-19","volume":"4","author":"H Xin","year":"2019","unstructured":"Xin H, Mohiuddin F, Tran J, et al. Experimental mouse models of disseminated Candida auris infection. mSphere. 2019;4(5):00339\u201319.","journal-title":"mSphere"},{"key":"919_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03364-19","author":"NA Chow","year":"2020","unstructured":"Chow NA, Mu\u00f1oz JF, Gade L, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio. 2020. https:\/\/doi.org\/10.1128\/mbio.03364-19.","journal-title":"mBio"},{"issue":"3","key":"919_CR15","doi-asserted-by":"publisher","first-page":"e01625","DOI":"10.1128\/AAC.01625-19","volume":"64","author":"SR Torres","year":"2020","unstructured":"Torres SR, Pichowicz A, Torres-Velez F, et al. Impact of Candida auris Infection in a neutropenic murine model. Antimicrob Agents Chemother. 2020;64(3):e01625-e1719. https:\/\/doi.org\/10.1128\/AAC.01625-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"919_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1080\/22221751.2020.1771218","volume":"9","author":"L Forg\u00e1cs","year":"2020","unstructured":"Forg\u00e1cs L, Borman AM, Pr\u00e9post E, et al. Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model. Emerg Microbes Infect. 2020;9(1):1160\u20139. https:\/\/doi.org\/10.1080\/22221751.2020.1771218.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"919_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2217\/fmb.15.34","volume":"10","author":"MR Ananda-Rajah","year":"2015","unstructured":"Ananda-Rajah MR, Kontoyiannis D. Isavuconazole: a new extended spectrum triazole for invasive mold diseases. Future Microbiol. 2015;10(5):693\u2013708. https:\/\/doi.org\/10.2217\/fmb.15.34.","journal-title":"Future Microbiol"},{"key":"919_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myae083","author":"GR Thompson","year":"2024","unstructured":"Thompson GR, Chen SCA, Alfouzan AW, et al. A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole. Med Mycol. 2024. https:\/\/doi.org\/10.1093\/mmy\/myae083.","journal-title":"Med Mycol"},{"issue":"4","key":"919_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/antibiotics10040355","volume":"10","author":"U Caballero","year":"2021","unstructured":"Caballero U, Kim S, Eraso E, et al. In vitro synergistic interactions of isavuconazole and echinocandins against Candida auris. Antibiotics (Basel). 2021;10(4):355.","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"919_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/psp4.12949","volume":"12","author":"U Caballero","year":"2023","unstructured":"Caballero U, Eraso E, Quind\u00f3s G, Vozmediano V, Schmidt S, Jauregizar N. PK\/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris. CPT Pharmacometrics Syst Pharmacol. 2023;12(6):770\u201382. https:\/\/doi.org\/10.1002\/psp4.12949.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"919_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/jof6040324","volume":"6","author":"M Ellsworth","year":"2020","unstructured":"Ellsworth M, Ostrosky-Zeichner L. Isavuconazole: mechanism of action, clinical efficacy, and resistance. J Fungi (Basel). 2020;6(4):324. https:\/\/doi.org\/10.3390\/jof6040324.","journal-title":"J Fungi (Basel)"},{"issue":"10","key":"919_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/mmy\/myab032","volume":"59","author":"F Nagy","year":"2021","unstructured":"Nagy F, T\u00f3th Z, Nyikos F, et al. In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms. Med Mycol. 2021;59(10):1015\u201323. https:\/\/doi.org\/10.1093\/mmy\/myab032.","journal-title":"Med Mycol"},{"key":"919_CR23","doi-asserted-by":"publisher","first-page":"1049959","DOI":"10.3389\/fcimb.2022.1049959","volume":"12","author":"T Zhang","year":"2022","unstructured":"Zhang T, Shen Y, Feng S. Clinical research advances of isavuconazole in the treatment of invasive fungal diseases. Front Cell Infect Microbiol. 2022;12:1049959. https:\/\/doi.org\/10.3389\/fcimb.2022.1049959.","journal-title":"Front Cell Infect Microbiol"},{"key":"919_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02031-20","author":"MA Pfaller","year":"2021","unstructured":"Pfaller MA, Messer SA, Deshpande LM, et al. Evaluation of synergistic activity of isavuconazole or voriconazole plus anidulafungin and the occurrence and genetic characterization of Candida auris detected in a surveillance program. Antimicrob Agents Chemother. 2021. https:\/\/doi.org\/10.1128\/aac.02031-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"919_CR25","doi-asserted-by":"publisher","first-page":"e00485","DOI":"10.1128\/AAC.00485-17","volume":"61","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Prakash A, Meletiadis J, et al. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother. 2017;61(6):e00485-e517. https:\/\/doi.org\/10.1128\/AAC.00485-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"919_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s40262-023-01305-8","volume":"62","author":"AME Jansen","year":"2023","unstructured":"Jansen AME, Mertens B, Spriet I, et al. Population pharmacokinetics of total and unbound isavuconazole in critically Ill patients: implications for adaptive dosing strategies. Clin Pharmacokinet. 2023;62(12):1701\u201311. https:\/\/doi.org\/10.1007\/s40262-023-01305-8.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"919_CR27","doi-asserted-by":"publisher","first-page":"0071021","DOI":"10.1128\/mSphere.00710-21","volume":"6","author":"\u00c1 Jakab","year":"2021","unstructured":"Jakab \u00c1, Balla N, Ragy\u00e1k \u00c1, et al. Transcriptional profiling of the Candida auris response to exogenous farnesol exposure. mSphere. 2021;6(5):0071021.","journal-title":"mSphere"},{"issue":"4","key":"919_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02278-23","volume":"12","author":"\u00c1 Jakab","year":"2024","unstructured":"Jakab \u00c1, Kov\u00e1cs F, Balla N, et al. Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment. Microbiol Spectr. 2024;12(4): e0227823. https:\/\/doi.org\/10.1128\/spectrum.02278-23.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"919_CR29","first-page":"532","volume":"15","author":"P Chomczynski","year":"1993","unstructured":"Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993;15(3):532\u20134.","journal-title":"Biotechniques"},{"issue":"1","key":"919_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310. https:\/\/doi.org\/10.1093\/nar\/30.1.207.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"919_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, et al. SRplot: a free online platform for data visualization and graphing. PLoS ONE. 2023;18(11): e0294236. https:\/\/doi.org\/10.1371\/journal.pone.0294236.","journal-title":"PLoS ONE"},{"issue":"11","key":"919_CR32","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1128\/AAC.01111-13","volume":"57","author":"SJ Howard","year":"2013","unstructured":"Howard SJ, Lass-Fl\u00f6rl C, Cuenca-Estrella M, et al. Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method. Antimicrob Agents Chemother. 2013;57(11):5426\u201331. https:\/\/doi.org\/10.1128\/AAC.01111-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"919_CR33","doi-asserted-by":"publisher","first-page":"634.e1","DOI":"10.1016\/j.cmi.2019.02.007","volume":"25","author":"M Desnos-Ollivier","year":"2019","unstructured":"Desnos-Ollivier M, Bretagne S, Boulli\u00e9 A, et al. Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015\u20132017). Clin Microbiol Infect. 2019;25(5):634.e1-e4. https:\/\/doi.org\/10.1016\/j.cmi.2019.02.007.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"919_CR34","doi-asserted-by":"publisher","first-page":"21448","DOI":"10.1038\/s41598-020-78588-5","volume":"10","author":"P Schwarz","year":"2020","unstructured":"Schwarz P, Bidaud AL, Dannaoui E. In vitro synergy of isavuconazole in combination with colistin against Candida auris. Sci Rep. 2020;10(1):21448. https:\/\/doi.org\/10.1038\/s41598-020-78588-5.","journal-title":"Sci Rep"},{"issue":"6","key":"919_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02276-21","volume":"66","author":"R Shivarathri","year":"2022","unstructured":"Shivarathri R, Jenull S, Chauhan M, et al. Comparative transcriptomics reveal possible mechanisms of amphotericin B resistance in Candida auris. Antimicrob Agents Chemother. 2022;66(6): e0227621. https:\/\/doi.org\/10.1128\/aac.02276-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"919_CR36","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1128\/AAC.50.4.1311-1319.2006","volume":"50","author":"A Lepak","year":"2006","unstructured":"Lepak A, Nett J, Lincoln L, et al. Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrob Agents Chemother. 2006;50(4):1311\u20139. https:\/\/doi.org\/10.1128\/AAC.50.4.1311-1319.2006.","journal-title":"Antimicrob Agents Chemother"},{"key":"919_CR37","doi-asserted-by":"publisher","first-page":"1323619","DOI":"10.3389\/fcimb.2023.1323619","volume":"13","author":"BV Ar\u00e9valo-Jaimes","year":"2023","unstructured":"Ar\u00e9valo-Jaimes BV, Admella J, Blanco-Cabra N, et al. Culture media influences Candida parapsilosis growth, susceptibility, and virulence. Front Cell Infect Microbiol. 2023;13:1323619. https:\/\/doi.org\/10.3389\/fcimb.2023.1323619.","journal-title":"Front Cell Infect Microbiol"},{"key":"919_CR38","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760200294ER","volume":"115","author":"MM Weerasekera","year":"2020","unstructured":"Weerasekera MM, Wijesinghe GK, Jayarathna TA, et al. Culture media profoundly affect Candida albicans and Candida tropicalis growth, adhesion and biofilm development. Mem Inst Oswaldo Cruz. 2020;115: e200294. https:\/\/doi.org\/10.1590\/0074-02760200294ER.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"919_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mimet.2016.09.011","volume":"130","author":"Y Tan","year":"2016","unstructured":"Tan Y, Leonhard M, Ma S, et al. Influence of culture conditions for clinically isolated non-albicans Candida biofilm formation. J Microbiol Methods. 2016;130:123\u20138. https:\/\/doi.org\/10.1016\/j.mimet.2016.09.011.","journal-title":"J Microbiol Methods"},{"issue":"6","key":"919_CR40","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1128\/AAC.49.6.2226-2236.2005","volume":"49","author":"TT Liu","year":"2005","unstructured":"Liu TT, Lee RE, Barker KS, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother. 2005;49(6):2226\u201336. https:\/\/doi.org\/10.1128\/AAC.49.6.2226-2236.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"919_CR41","doi-asserted-by":"crossref","unstructured":"Hunsaker EW, Yu CA, Franz KJ. 2021 Copper Availability Influences the Transcriptomic Response of Candida albicans to Fluconazole Stress. G3 Bethesda 11(4):65","DOI":"10.1093\/g3journal\/jkab065"},{"issue":"5","key":"919_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00678-24","volume":"12","author":"S Choudhary","year":"2024","unstructured":"Choudhary S, Mundodi V, Smith AD, et al. Genome-wide translational response of Candida albicans to fluconazole treatment. Microbiol Spectr. 2024;12(5): e0067824. https:\/\/doi.org\/10.1128\/spectrum.00678-24.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"919_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03526-23","volume":"12","author":"J Li","year":"2024","unstructured":"Li J, Aubry L, Brandalise D, et al. Upc2-mediated mechanisms of azole resistance in Candida auris. Microbiol Spectr. 2024;12(2): e0352623. https:\/\/doi.org\/10.1128\/spectrum.03526-23.","journal-title":"Microbiol Spectr"},{"key":"919_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.708009","volume":"12","author":"W Zhou","year":"2021","unstructured":"Zhou W, Li X, Lin Y, et al. A comparative transcriptome between anti-drug sensitive and resistant Candida auris in China. Front Microbiol. 2021;12: 708009. https:\/\/doi.org\/10.3389\/fmicb.2021.708009.","journal-title":"Front Microbiol"},{"key":"919_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.bbamem.2013.10.015","volume":"1838","author":"C Sgherri","year":"2014","unstructured":"Sgherri C, Porta A, Castellano S, et al. Effects of azole treatments on the physical properties of Candida albicans plasma membrane: a spin probe EPR study. Biochim Biophys Acta. 2014;1838:465\u201373.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"919_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/EC.00271-14","volume":"14","author":"S Liu","year":"2015","unstructured":"Liu S, Hou Y, Liu W, et al. Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets. Eukaryot Cell. 2015;14(4):324\u201334. https:\/\/doi.org\/10.1128\/EC.00271-14.","journal-title":"Eukaryot Cell"},{"issue":"1","key":"919_CR47","doi-asserted-by":"publisher","first-page":"e00715","DOI":"10.1128\/mSphere.00715-18","volume":"4","author":"A Luna-Tapia","year":"2019","unstructured":"Luna-Tapia A, DeJarnette C, Sansevere E, et al. The Vacuolar Ca2+ ATPase Pump Pmc1p Is Required for Candida albicans Pathogenesis. mSphere. 2019;4(1):e00715-18.","journal-title":"mSphere"},{"key":"919_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2021.126786","volume":"249","author":"W Li","year":"2021","unstructured":"Li W, Shrivastava M, Lu H, et al. Calcium-calcineurin signaling pathway in Candida albicans: a potential drug target. Microbiol Res. 2021;249: 126786. https:\/\/doi.org\/10.1016\/j.micres.2021.126786.","journal-title":"Microbiol Res"},{"issue":"12","key":"919_CR49","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1128\/EC.00274-06","volume":"5","author":"LE Cowen","year":"2006","unstructured":"Cowen LE, Carpenter AE, Matangkasombut O, et al. Genetic architecture of Hsp90-dependent drug resistance. Eukaryot Cell. 2006;5(12):2184\u20138. https:\/\/doi.org\/10.1128\/EC.00274-06.","journal-title":"Eukaryot Cell"},{"key":"919_CR50","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3389\/fmicb.2019.03100","volume":"10","author":"M Lange","year":"2020","unstructured":"Lange M, Peiter E. Calcium transport proteins in fungi: the phylogenetic diversity of their relevance for growth, virulence, and stress resistance. Front Microbiol. 2020;10:3100. https:\/\/doi.org\/10.3389\/fmicb.2019.03100.","journal-title":"Front Microbiol"},{"issue":"7","key":"919_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000532","volume":"5","author":"SD Singh","year":"2009","unstructured":"Singh SD, Robbins N, Zaas AK, et al. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 2009;5(7): e1000532. https:\/\/doi.org\/10.1371\/journal.ppat.1000532.","journal-title":"PLoS Pathog"},{"issue":"1","key":"919_CR52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41467-017-00547-y","volume":"8","author":"JL Xie","year":"2017","unstructured":"Xie JL, Qin L, Miao Z, et al. The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation. Nat Commun. 2017;8(1):499. https:\/\/doi.org\/10.1038\/s41467-017-00547-y.","journal-title":"Nat Commun"},{"issue":"3","key":"919_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01820-21","volume":"9","author":"CL Ennis","year":"2021","unstructured":"Ennis CL, Hernday AD, Nobile CJ. A markerless CRISPR-mediated system for genome editing in Candida auris reveals a conserved role for cas5 in the caspofungin response. Microbiol Spectr. 2021;9(3): e0182021. https:\/\/doi.org\/10.1128\/Spectrum.01820-21.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"919_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41467-019-08339-2","volume":"10","author":"J Gao","year":"2019","unstructured":"Gao J, Wang H, Li Z, et al. Candida albicans gains azole resistance by altering sphingolipid composition. Nat Commun. 2019;10(1):317. https:\/\/doi.org\/10.1038\/s41467-019-08339-2.","journal-title":"Nat Commun"},{"key":"919_CR55","doi-asserted-by":"publisher","first-page":"008","DOI":"10.1093\/femsyr\/foae008","volume":"24","author":"B Ali","year":"2024","unstructured":"Ali B, Kumar M, Kumar P, et al. Sphingolipid diversity in Candida auris: unraveling interclade and drug resistance fingerprints. FEMS Yeast Res. 2024;24:008.","journal-title":"FEMS Yeast Res"},{"issue":"1","key":"919_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/jof8010061","volume":"8","author":"P Pais","year":"2022","unstructured":"Pais P, Galocha M, Calif\u00f3rnia R, et al. Characterization of the Candida glabrata transcription factor CgMar1: role in azole susceptibility. J Fungi (Basel). 2022;8(1):61. https:\/\/doi.org\/10.3390\/jof8010061.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"919_CR57","doi-asserted-by":"publisher","first-page":"e00334","DOI":"10.1128\/mSphere.00334-18","volume":"3","author":"R Kean","year":"2018","unstructured":"Kean R, Delaney C, Sherry L, et al. Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. mSphere. 2018;3(4):e00334-18.","journal-title":"mSphere"},{"issue":"6665","key":"919_CR58","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.adf8972","volume":"381","author":"DJ Santana","year":"2023","unstructured":"Santana DJ, Anku JAE, Zhao G, et al. A Candida auris-specific adhesin, Scf1, governs surface association, colonization, and virulence. Science. 2023;381(6665):1461\u20137. https:\/\/doi.org\/10.1126\/science.adf8972.","journal-title":"Science"},{"issue":"1","key":"919_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tim.2023.10.008","volume":"32","author":"A Balakumar","year":"2024","unstructured":"Balakumar A, Bernstein D, Thangamani S. The adhesin SCF1 mediates Candida auris colonization. Trends Microbiol. 2024;32(1):4\u20135. https:\/\/doi.org\/10.1016\/j.tim.2023.10.008.","journal-title":"Trends Microbiol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-024-00919-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:56:24Z","timestamp":1740509784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-024-00919-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s11046-024-00919-1","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"type":"print","value":"0301-486X"},{"type":"electronic","value":"1573-0832"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"5"}}